
usd pm et
summari develop manufactur distribut product servic companion anim
veterinari livestock poultri water test dairi market world-wide
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
aug stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
laboratori inc lift
target base
above-p forward price-to-earnings ratio
averag ep
estim trade peer due
resili oper model attract
growth opportun ep vs
exceed estim
primarili stronger-than-expect
oper margin lower ep
estim maintain
ep sale grew yoy
organ million ahead
mostli attribut companion
anim group recur
revenu growth organ
prior two quarter lower
ep guidanc reflect neg
impact relat ceo transit charg
also provid preliminari outlook
organ revenu growth
ep growth fall in-lin
see demand product servic
remain strong pet ownership increas global
consum spend pet-rel servic
could lose market share competitor face
increas price pressur think
maintain net debt ebitda
ratio recent year
concern macroeconom downturn think
could pressur given product
servic tie discretionari consum spend
jan ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview inc togeth subsidiari develop manufactur
distribut product servic primarili companion anim veterinari livestock poultri
water test dairi market world-wide compani provid point-of-car veterinari diagnost
product includ instrument consum rapid assay veterinari refer laboratori
diagnost consult servic practic manag system servic digit imag
system veterinarian biolog materi test laboratori anim diagnost instrument
servic biomed research commun also offer diagnost health-monitor food
safeti test product livestock poultri dairi market product test water variou
microbiolog contamin point-of-car electrolyt blood ga analyz use
oper three primari busi segment companion anim group water qualiti
product livestock poultri dairi oper segment contain busi
meet quantit threshold report segment
companion anim group total sale provid veterinarian diagnost capabl
inform manag solut enhanc health well-b pet diagnost
provid diagnost capabl meet veterinarian divers need varieti modal
includ in-clin diagnost solut outsid refer laboratori servic in-clin diagnost
solut compris vetlab suit in-clin chemistri hematolog immunoassay
urinalysi coagul analyz associ proprietari consum product provid real-tim
refer lab qualiti diagnost result broad rang single-us handheld snap rapid assay
test kit provid quick accur conveni point-of-car diagnost test result varieti
companion anim diseas health condit offer commerci refer laboratori diagnost
consult servic veterinarian world-wide compani refer laboratori offer larg
select test diagnost panel detect number diseas state condit
anim includ test run in-clin veterinari practic instrument rapid
assay diagnost imag system captur radiograph imag digit form replac
tradit x-ray film film develop process gener requir use hazard
chemic darkroom
water qualiti product segment provid innov test solut easi rapid
accur detect quantif variou microbiolog paramet water princip
product colilert colisur test simultan detect presenc total
coliform coli water compani water test use govern laboratori water
util privat certifi laboratori test drink water complianc regulatori standard
includ environment protect agenc standard test also use evalu water
use product process exampl beverag pharmaceut applic
evalu bottl water recreat water wastewat water privat well
livestock poultri dairi segment sell diagnost test servic relat instrument
use manag health statu livestock poultri improv bovin reproduct
effici ensur qualiti safeti milk food livestock poultri diagnost
product purchas govern privat laboratori provid test servic livestock
veterinarian produc processor princip livestock poultri diagnost product includ
test bovin viral diarrhea viru porcin reproduct respiratori syndrom
segment sell point-of-car analyz relat consum use human medic
hospit clinic measur electrolyt blood gase acid-bas balanc glucos lactat blood urea
nitrogen ioniz calcium calcul paramet base excess anion gap
opti analyz use primarili emerg room oper room cardiac monitor area
locat time-crit diagnost test perform within hospit set
market profil compet mani compani rang larg human pharmaceut
medic diagnost compani small busi focus anim health companion anim
group primari north american competitor includ antech diagnost unit vca inc abaxi inc
heska corpor zoeti inc electrolyt blood ga analyz market compet
primarili larg human medic diagnost compani radiomet a/ siemen medic
solut diagnost instrument laboratori compani abbott diagnost divis abbott
laboratori roch diagnost corpor
financi experienc revenu growth billion follow growth
five-year compound annual growth rate compound-annual-growth-rate revenu high
net debt total capit ratio march allevi concern around idxx
leverag net debt trailing-twelve-month ebitda consist free cash flow
gener gener million slightli million
senior director
world-wide oper
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu usd
neutral sinc octob technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
equip sub-industri next month
neutral continu expect compani
sub-industri achiev robust organ
growth posit macroeconom environ
compani gener benefit new
product launch laxer food drug
administr fda technolog advanc
sub-industri also mani product area
histor recession-resist
equip use non-elect procedur
howev valuat health care equip
compani elev rel
composit suggest posit
fundament reflect share
think higher valuat
sub-industri mostli warrant
strong recent margin expans revenu
growth associ robust product
expect sub-industri earn rise
high-single-digit percentag driven
continu pipelin innov new product
emerg market expans speed
new product come market
increas recent year
success effort fda reduc
approv time medic devic
time see price pressur incess
headwind medic equip compani
impact china-u trade war appear
insignific far medic
equip compani especi sinc
base medic equip manufactur
sourc insignific amount product
input china addit
chines govern seek lower health
care cost provid better health care
insul medic equip
sub-industri mount trade tension
larg medic equip target
chines tariff mean certain
compani
like
hurt trade tension howev bigger
concern medic equip
manufactur potenti trade
tension caus signific slowdown
possibl threat state american
health care system lawsuit texa
rule unconstitut
current expect upheld upon
appeal although decis could take
coupl year reach democrat
took control hous repres
period think
see substanti effort
republican trump administr
tri repeal
anoth legisl issu could impact
medic equip manufactur
potenti return medic devic tax
medic devic tax suspend
end congress fail
repeal suspend tax medic
devic manufactur could significantli
gener see posit long-term
fundament includ increas global
demand cost-effect value-bas
health care age popul rise
outlay result steadi flow
innov product revenu growth
year-to-d septemb
vs increas valu
 composit index
vs declin
base index
five-year market price perform
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
pm et cfra maintain hold opinion share inc
rais target above-p
ep estim think multipl appropri given attract
growth opportun robust recur revenu ep vs
higher estim lower ep estim
initi ep estim revenu increas yoy
organ million companion anim group segment sale
led way yoy growth revenu organ sale continu
benefit expand premium instrument base benefit new test
innov refer laboratori diagnost consult servic also saw
robust growth quarter organ sale growth yoy sale
total continu domin growth increas yoy versu growth
intern sale despit attract growth opportun think
share current near fair valu /colin scarola kevin huang cfa
hold sell rais target
above-p ep estim think
multipl appropri given growth opportun recur
revenu ep vs higher estim
lower ep sale increas organ
million sale largest busi companion anim
group grew organ announc revenu growth
outlook rang organ
expand instal global base catalyst chemistri analyz
refer lab diagnost consult servic part growth abroad
weaker expect due unfavor weather condit europ
constrain visit downward stock price correct octob
find trade much closer fair valu rais
opinion hold /kevin huang cfa
analyst research note compani news
pm et cfra maintain sell opinion share
inc lift target base
above-p forward price-to-earnings ratio averag
ep estim trade peer due resili oper
model attract growth opportun ep vs exceed
estim primarili stronger-than-expect oper
margin lower ep estim maintain
ep sale grew yoy organ million ahead
expect quarter out-performance mostli attribut
companion anim group recur revenu growth
organ prior two quarter lower ep
guidanc reflect neg impact relat ceo transit
charg also provid preliminari outlook
organ revenu growth ep growth fall in-lin
pm et cfra reiter sell opinion share
inc rais target base
above-p forward price-to-earnings ratio averag
ep estim trade peer due attract growth
opportun robust recur revenu lift ep estim
ep ep vs
beat expect primarili
stronger-than-expect oper margin reflect gross margin gain
better-than-expect oper leverag sale increas yoy
organ million slightli short expect diagnost
recur revenu grew yoy organ net estim headwind
relat brexit expect lower revenu growth
stronger-than-expect currenc headwind disrupt oper
refin howev anticip higher full-year oper margin
growth off-set impact weaker revenu growth /kevin huang cfa
pm et cfra lower opinion share
sell hold lower opinion share
find trade expens valuat recent
think recent share valuat fulli reflect risk relat
potenti slowdown macroeconom growth share
significantli outperform industri peer out-perform
reflect expens forward price-to-earnings ratio compani
five-year averag despit consensu expect slowdown ep
growth end achiev ep compound annual growth rate
compound-annual-growth-rate expect ep compound-annual-growth-rate
avoid fallout headlin around human health
care cost compani avoid concern slow macroeconom growth
think could experi sever multipl compress
macroeconom growth slow pet owner gener pay cash pocket
veterinari servic /kevin huang cfa
pm et cfra keep hold opinion share inc
rais target base
above-p ratio ep estim
multipl slightli averag reflect attract growth
opportun robust recur revenu ep vs exce
consensu expect rais ep estim
sale increas yoy organ million driven
companion anim group diagnost recur revenu growth
organ growth diagnost recur revenu primarili driven
volum growth aid net price realiz addit
better-than-expect oper margin basi point higher
prior-year period due gross margin gain oper leverag
lift full-year ep expect reflect oper margin
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
